LNLin Ning

Lin Ning

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lin Ning has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Hao Lin

    School of Life Science and Technology and Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China

    3 shared publications
  • Hasan Zulfiqar

    Yangtze Delta Region Institute (Huzhou), University of Electronic Science and Technology of China, Huzhou, China

    2 shared publications
  • Nanchao Luo

    School of Computer Science and Technology Aba Teachers College Aba Sichuan China

    2 shared publications
  • Yang Zhang

    Innovative Institute of Chinese Medicine and Pharmacy Academy for Interdiscipline Chengdu University of Traditional Chinese Medicine Chengdu China

    2 shared publications
  • Baocai Zhong

    School of Computer and Software, Chengdu Neusoft University, Chengdu, China

    1 shared publication
  • Basharat Ahmad

    School of Life Science and Technology and Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu 610054, China

    1 shared publication

Latest Publications

  • Open Access

    siRNAEfficacyDB: An experimentally supported small interfering RNA efficacy database

    by Yang Zhang, Ting Yang, Yu Yang, Dongsheng Xu, Yucheng Hu, Shuo Zhang, Nanchao Luo, Lin Ning, Liping Ren

    Small interfering RNA (siRNA) has revolutionised biomedical research and drug development through precise post‐transcriptional gene silencing technology. Despite its immense potential, siRNA therapy still faces technical challenges, such as delivery efficiency, targeting specificity, and molecular stability. To address these challenges and facilitate siRNA drug development, we have developed siRNAEfficacyDB, a comprehensive database that integrates experimentally validated siRNA efficacy data. This database contains 3544 siRNA records, covering 42 target genes and 5 cell lines. It provides detailed information on siRNA sequences, target genes, inhibition efficiencies, experimental techniques, cell lines, siRNA concentrations, and incubation times. siRNAEfficacyDB offers a user‐friendly web interface that makes it easy to query, browse and analyse data, enabling efficient access to siRNA‐related information. In summary, siRNAEfficacyDB provides a useful data foundation for siRNA drug design and optimisation, serving as a valuable resource for advancing computer‐aided siRNA design research and nucleic acid drug development. siRNAEfficacyDB is freely available at https://cellknowledge.com.cn/siRNAEfficacy for non‐commercial use.


  • A protein pre-trained model-based approach for the identification of the liquid-liquid phase separation (LLPS) proteins

    by Zahoor Ahmed, Kiran Shahzadi, Sebu Aboma Temesgen, Basharat Ahmad, Xiang Chen, Lin Ning, Hasan Zulfiqar, Hao Lin, Yan-Ting Jin


  • Open Access

    E-MuLA: An Ensemble Multi-Localized Attention Feature Extraction Network for Viral Protein Subcellular Localization

    by Grace-Mercure Bakanina Kissanga, Hasan Zulfiqar, Shenghan Gao, Sophyani Banaamwini Yussif, Biffon Manyura Momanyi, Lin Ning, Hao Lin, Cheng-Bing Huang

    Accurate prediction of subcellular localization of viral proteins is crucial for understanding their functions and developing effective antiviral drugs. However, this task poses a significant challenge, especially when relying on expensive and time-consuming classical biological experiments. In this study, we introduced a computational model called E-MuLA, based on a deep learning network that combines multiple local attention modules to enhance feature extraction from protein sequences. The superior performance of the E-MuLA has been demonstrated through extensive comparisons with LSTM, CNN, AdaBoost, decision trees, KNN, and other state-of-the-art methods. It is noteworthy that the E-MuLA achieved an accuracy of 94.87%, specificity of 98.81%, and sensitivity of 84.18%, indicating that E-MuLA has the potential to become an effective tool for predicting virus subcellular localization.


  • ncRS: A resource of non-coding RNAs in sepsis

    by Baocai Zhong, Yongfang Dai, Li Chen, Xinying Xu, Yuxi Lan, Leyao Deng, Liping Ren, Nanchao Luo, Lin Ning


  • PSnoD: identifying potential snoRNA-disease associations based on bounded nuclear norm regularization

    by Zijie Sun, Qinlai Huang, Yuhe Yang, Shihao Li, Hao Lv, Yang Zhang, Hao Lin, Lin Ning

    Many studies have proved that small nucleolar RNAs (snoRNAs) play critical roles in the development of various human complex diseases. Discovering the associations between snoRNAs and diseases is an important step toward understanding the pathogenesis and characteristics of diseases. However, uncovering associations via traditional experimental approaches is costly and time-consuming. This study proposed a bounded nuclear norm regularization-based method, called PSnoD, to predict snoRNA-disease associations. Benchmark experiments showed that compared with the state-of-the-art methods, PSnoD achieved a superior performance in the 5-fold stratified shuffle split. PSnoD produced a robust performance with an area under receiver-operating characteristic of 0.90 and an area under precision-recall of 0.55, highlighting the effectiveness of our proposed method. In addition, the computational efficiency of PSnoD was also demonstrated by comparison with other matrix completion techniques. More importantly, the case study further elucidated the ability of PSnoD to screen potential snoRNA-disease associations. The code of PSnoD has been uploaded to https://github.com/linDing-groups/PSnoD. Based on PSnoD, we established a web server that is freely accessed via http://psnod.lin-group.cn/.


  • Open Access

    SSH2.0: A Better Tool for Predicting the Hydrophobic Interaction Risk of Monoclonal Antibody

    by Yuwei Zhou, Shiyang Xie, Yue Yang, Lixu Jiang, Siqi Liu, Wei Li, Hamza Bukari Abagna, Lin Ning, Jian Huang

    Therapeutic antibodies play a crucial role in the treatment of various diseases. However, the success rate of antibody drug development is low partially because of unfavourable biophysical properties of antibody drug candidates such as the high aggregation tendency, which is mainly driven by hydrophobic interactions of antibody molecules. Therefore, early screening of the risk of hydrophobic interaction of antibody drug candidates is crucial. Experimental screening is laborious, time-consuming, and costly, warranting the development of efficient and high-throughput computational tools for prediction of hydrophobic interactions of therapeutic antibodies. In the present study, 131 antibodies with hydrophobic interaction experiment data were used to train a new support vector machine-based ensemble model, termed SSH2.0, to predict the hydrophobic interactions of antibodies. Feature selection was performed against CKSAAGP by using the graph-based algorithm MRMD2.0. Based on the antibody sequence, SSH2.0 achieved the sensitivity and accuracy of 100.00 and 83.97%, respectively. This approach eliminates the need of three-dimensional structure of antibodies and enables rapid screening of therapeutic antibody candidates in the early developmental stage, thereby saving time and cost. In addition, a web server was constructed that is freely available at http://i.uestc.edu.cn/SSH2/.